GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 120 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $333,508 | -11.8% | 193,900 | 0.0% | 0.01% | -11.1% |
| Q2 2023 | $378,105 | -25.6% | 193,900 | +6.0% | 0.01% | -30.8% |
| Q1 2023 | $508,462 | -28.5% | 182,900 | -11.2% | 0.01% | -27.8% |
| Q4 2022 | $710,700 | +119.4% | 206,000 | +63.5% | 0.02% | +100.0% |
| Q3 2022 | $324,000 | +478.6% | 126,000 | +445.5% | 0.01% | +800.0% |
| Q2 2022 | $56,000 | -41.1% | 23,100 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $95,000 | -90.5% | 23,100 | -70.4% | 0.00% | -89.5% |
| Q4 2021 | $1,004,000 | -38.0% | 78,100 | -47.9% | 0.02% | -38.7% |
| Q3 2021 | $1,620,000 | +18.2% | 150,000 | 0.0% | 0.03% | +24.0% |
| Q2 2021 | $1,370,000 | -17.0% | 150,000 | -14.3% | 0.02% | -19.4% |
| Q1 2021 | $1,650,000 | +139.1% | 175,000 | 0.0% | 0.03% | +106.7% |
| Q4 2020 | $690,000 | – | 175,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $17,536,000 | 1.82% |
| EcoR1 Capital, LLC | 3,421,287 | $13,480,000 | 0.72% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $8,123,000 | 0.63% |
| BVF INC/IL | 2,695,418 | $10,620,000 | 0.42% |
| Column Group LLC | 869,493 | $3,426,000 | 0.31% |
| Avidity Partners Management LP | 2,122,064 | $8,361,000 | 0.27% |
| Redmile Group, LLC | 3,059,794 | $12,056,000 | 0.15% |
| SkyOak Wealth, LLC | 69,778 | $275,000 | 0.09% |
| Tekla Capital Management LLC | 419,005 | $1,651,000 | 0.06% |
| Blackstone Inc. | 2,567,445 | $10,116,000 | 0.04% |